cDNA Clone Vectors Market Size, Share & Trends Analysis Report By Type (Rat, Cat, Dog, Monkey, Human, Others), By Application (BioScience Companies, Hospital and Clinics, University and Institutions, Others), By Region, And By Segment Forecasts, 2024-2031.
cDNA Clone Vectors Market Size is valued at USD 120.8 Mn in 2023 and is predicted to reach USD 258.1 Mn by the year 2031 at a 10.2% CAGR during the forecast period for 2024-2031. cDNA clone vectors are tools used in molecular biology to clone and express complementary DNA (cDNA) derived from messenger RNA (mRNA). These vectors typically contain elements such as promoter regions for gene expression, selection markers for identifying successfull...
Report ID: 2544 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Vitamin B12 API Market Size, Share & Trends Analysis Report By Type (Cyanocobalamin, Hydroxocobalamin (Hydroxocobalamin Chloride, Hydroxocobalamin Acetate, Hydroxocobalamin Base), Others (Methylcobalamin, etc.)), By Form (Powder, Liquid), By Grade, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031.
Vitamin B12 API Market Size is predicted to grow at a 5.7% CAGR during the forecast period for 2024-2031. Vitamin B12(cobalamin) is a vital vitamin necessary for various important body processes, such as the creation of red blood cells as well as the synthesis of DNA. The API for vitamin B12 refers to the unadulterated form of the vitamin, typically acquired through chemical synthesis or fermentation. The active ingredient is responsible for t...
Report ID: 2536 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 179
Non-Viral Transfection Reagents Market Size, Share & Trends Analysis Distribution by Type of Non-Viral Transfection System (Non-Viral Transfection Reagents (chemical & physical), Electroporation-based Transfection Systems), Area of Application (Clinical Applications, Research Applications), End-User (Academic and Research Institutions, Pharmaceutical Companies) and Segment Forecasts, 2023-2031
Non-Viral Transfection Reagents Market Size is valued at USD 649.1 Mn in 2023 and is predicted to reach USD 1,157.5 Mn by the year 2031 at an 7.7% CAGR during the forecast period for 2024-2031. Non-viral transfection reagents represent a significant advancement in genetic manipulation techniques, offering researchers a diverse toolkit for delivering genetic material into cells. Among the several types of non-viral reagents, lipid-based formula...
Report ID: 2533 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Thermal Cyclers Market Share & Trends Analysis Report by End-user (Pharmaceutical Industries, Academic and Research Institutes, Diagnostic Laboratories), by Application, Diagnostics, Sequencing Cloning, Genotyping, Mutagenesis, Manufacturing and Quality Control Testing, Clinical Research, Forensics), by Type (Test Mesa Type, Floor Stand Type), by Product Type (Instruments, Accessories), By Region, and Segment Forecasts, 2023-2031
Thermal Cyclers Market Size is valued at USD 1.03 Bn in 2023 and is predicted to reach USD 1.86 Bn by the year 2031 at an 7.8% CAGR during the forecast period for 2024-2031. Thermal cyclers, also referred to as PCR (Polymerase Chain Reaction) machines or thermocyclers, are laboratory instruments used to amplify segments of DNA via the PCR process. They are essential tools in molecular biology, genetics, and various biological research and medic...
Report ID: 2535 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type, indication, end-user and route of administration, Region And Segment Forecasts, 2023-2031
Medical Nutrition Market Size is valued at USD 13.1 Bn in 2023 and is predicted to reach USD 20.2 Bn by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. The escalating occurrence of malnutrition among adults and the surge in obesity rates, coupled with the increasing prevalence of chronic diseases like cancer and diabetes, are primary drivers propelling market growth. Oral clinical nutrition, comprising vitamins, proteins...
Report ID: 2525 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Cell and Gene Therapy CRO Market Size, Share & Trends Analysis Report, By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Forecasts, 2024-2031
Cell and Gene Therapy CRO Market Size was valued at USD 1.46 Bn in 2023 and is predicted to reach USD 2.43 Bn by 2031 at a 6.7% CAGR during the forecast period for 2024-2031. Cell and gene therapy involves manipulating a patient's cells to introduce, remove, or alter specific genes in order to correct genetic problems. By getting to the bottom of hereditary disorders like cystic fibrosis and cancer, this treatment approach has promise. Clinica...
Report ID: 2521 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Bioseparation Systems Market Size, Share & Trends Analysis Report, By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical), By Region, Forecasts, 2024-2031
Bioseparation Systems Market Size was valued at USD 5.11 Bn in 2023 and is predicted to reach USD 10.56 Bn by 2031 at a 9.7% CAGR during the forecast period for 2024-2031. The bioseparation systems market is set to experience exponential growth propelled by a convergence of factors driving demand and innovation. Technological breakthroughs, including automation and artificial intelligence advancements, are revolutionizing production processes,...
Report ID: 2523 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Vinpocetine Supplements Market Size, Share & Trends Analysis Report, By Dosage Form (Tablets, Capsules, Powder, and Others), By Application (Dementia, Stroke, Hearing Loss, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-commerce, and Other), By Region, Forecasts, 2024-2031
Vinpocetine Supplements Market Size was valued at USD 268.3 Mn in 2023 and is predicted to reach USD 376.2 Mn by 2031 at a 4.5% CAGR during the forecast period for 2024-2031. The vinpocetine supplements encompass a range of dietary supplements containing vinpocetine, a synthetic compound derived from the periwinkle plant. Vinpocetine is purported to have potential cognitive and neurological benefits, including improving memory, enha...
Report ID: 2515 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Exosome Development and Manufacturing Services Market by Types of Service(s) Offered (Isolated Exosomes, Exosome Characterization, Purification, Chromatography, Engineering, Targeted Delivery, Diagnostic Biomarker, and Quality Control), Scale of Operation (Discovery / Research, Pre-Clinical, Clinical or Commercialized) and By Scalability, Region, and Segment Forecasts, 2024-2031
Exosome Development and Manufacturing Services Market Size is valued at USD 17.2 Bn in 2023 and is predicted to reach USD 62.8 Bn by the year 2031 at an 17.9% CAGR during the forecast period for 2024-2031. Exosomes, which range in diameter from 30 to 150 nm and are membrane-bound extracellular vesicles, are secreted into the extracellular environment by a wide variety of cell types. They develop inside the multivesicular bodies (MVBs) that con...
Report ID: 2514 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Therapeutic Proteins and Oral Vaccines Market Size, Share & Trends Analysis Report By Drug Class, By Distribution Channel, By Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, Other Applications), By Region, And By Segment Forecasts, 2024-2031
The Therapeutic Proteins and Oral Vaccines Market Size is valued at 239.91 Million in 2023 and is predicted to reach 436.26 Million by the year 2031 at a 8.1 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The rise in severe diseases such as cancer, diabetes, and autoimmune disorders has increased the demand for therapeutic proteins. These proteins are used for treating conditio...
Report ID: 1037 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Pharmaceuticals